Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies. The listing updates automatically on a daily basis.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link
OpportunityPostedClosing

Radiation Biodosimetry Assays and Devices (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

10/09/1802/11/19

Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH

10/05/1812/11/20

Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

10/05/1803/04/21

Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

10/05/1803/04/21

Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH

10/05/1804/15/21

Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]

Agency: NIH

Institutions: OBSSRNCINHLBINIANIAAANICHDNIDDKNIDANIMHNINRNIMHDNLM

10/03/1805/25/19

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINCCIHOBSSR

10/01/1801/07/22

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINCCIHOBSSR

10/01/1801/07/22

Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINIAMSNCCIHOBSSR

10/01/1801/07/22

Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINIAMSNCCIHOBSSR

10/01/1801/07/22

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/28/1807/11/21

FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for PEPFAR (President's Emergency Plan for AIDS Relief) Funded Countries

Agency: SUP

09/28/1809/30/20

Administrative Supplements to Cancer Center Support Grants to Strengthen the Research, Training, and Outreach Capacity of the Geographic Management of Cancer Health Disparities Program (Admin Suppl - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/24/1812/17/18

Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/21/1812/17/18

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANIDCRNIDANIMHNIMHD

09/21/1801/07/22

Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNCINEINIANIAAANIAMSNICHDNIDCRNIDDKNIDANINRNLMNCCIH

09/19/1811/12/19

Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNCINEINIANIAAANIAMSNICHDNIDCRNIDDKNIDANINRNLMNCCIH

09/19/1811/12/19

Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINHLBINIANIAAANIAMSNICHDNIDCRNIDDKNIDANINRNLMNCCIHOBSSRORWH

09/19/1803/12/20

The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)

Agency: NIH

Institutions: NCI

09/17/1802/22/19

Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)

Agency: NIH

Institutions: NCI

09/14/1811/15/18

Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating Center (DMACC) (U24 Clinical Trials Required)

Agency: NIH

Institutions: NCI

09/14/1811/15/18

Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/12/1805/07/20

Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/11/1812/07/18

HIV Prevention, Care, and Treatment Support for Church-related Hospitals and Clinics in the Republic of Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR)

Agency: CGH

09/10/1811/13/18

Fiscal Year 2019 Consolidated Innovative Nuclear Research

Agency: ID

09/10/1802/12/19

Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Optional).

Agency: NIH

Institutions: NCI

09/10/1801/09/19

Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINCCIHNIAAANICHD

09/10/1809/07/21

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/07/1808/11/21

Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1811/13/20

Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required)

Agency: NIH

Institutions: NCI

08/28/1811/15/18

Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDA

08/24/1801/08/19

Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDANIMHD

08/24/1801/08/19

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIP

08/22/1809/07/21

Strengthen Capacity of South African Government's Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care for Unstable HIV and TB/HIV Patients in the Republic of South Africa under PEPFAR

Agency: CGH

08/21/1810/22/18

Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINCCIHODS

08/14/1809/07/21

Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/13/1812/17/18

Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01 - No Clinical Trial Allowed)

Agency: NIH

Institutions: NCI

08/13/1812/17/18

Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

08/10/1801/09/19

Limited Competition: AIDS and Cancer Specimen Resource (ACSR)(UM1 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

08/09/1811/15/18

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/07/1809/07/21

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/07/1809/07/21

NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/02/1801/11/19

NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/02/1801/11/19

Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANINRNLMNCATSNCCIH

08/02/1803/12/20

2018 Human Exploration Research Opportunities (HERO)

Agency: JSC

08/01/1809/05/19

NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

07/30/1811/02/18

DoD Vision, Focused Translational Team Science Award

Agency: AMRAA

07/26/1812/04/18

Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIAMSNIDAODS

07/25/1809/07/21

Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNIMHD

07/25/1809/07/21

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/24/1803/08/21

Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHD

07/23/1810/31/18

DoD Breast Cancer, Breakthrough Award Levels 1 and 2

Agency: AMRAA

07/17/1811/15/18

DoD Breast Cancer, Breakthrough Award Levels 3 and 4

Agency: AMRAA

07/17/1812/13/18

Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINIAAANIMHDNCCIH

07/17/1809/07/21

Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINIAAANIMHDNINR

07/17/1809/07/21

Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINICHDODPOBSSR

07/12/1809/10/21

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIMHD

06/29/1806/27/20

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIEHS

06/29/1806/27/20

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIEHS

06/29/1806/27/20

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIMHD

06/29/1806/27/20

Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1809/10/20

Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1806/14/21

Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIBIBNIDCRNIDANIGMSNINDSNINRNIMHDNCCIHNCATS

06/20/1809/04/21

The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNCINEI

06/14/1806/03/21

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Agency: NIH

Institutions: ODS

06/13/1811/04/19

Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINEINHLBINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIEHSFICNCCIHORIP

06/05/1804/15/20

Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINIDDKNIEHSNCCIH

06/05/1804/15/20

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/24/1801/05/21

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/24/1801/05/21

DoD Prostate Cancer, Impact Award

Agency: AMRAA

05/21/1810/18/18

Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNIBIBNCI

05/16/1809/07/21

Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/30/1801/09/20

Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIAIDNCINIMH

04/20/1805/07/21

Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional).

Agency: NIH

Institutions: NCINIANIDCRNINR

04/03/1805/07/21

Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional).

Agency: NIH

Institutions: NCINIANIDCRNINR

04/03/1805/07/21

Revision Applications to National Cancer Institute (NCI) supported U01 Awards to Include Research on the NCIs Provocative Questions (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/03/1810/30/18

Revision Applications to National Cancer Institute (NCI) Supported R01 Awards to Include Research on the NCIs Provocative Questions (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/03/1810/30/18

Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/03/1810/30/18

Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/03/1810/30/18

Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNHLBINIAAANIDCRNINDS

03/30/1809/07/19

Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDDKNCINCCIHODS

03/29/1809/27/19

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/29/1811/19/20

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHD

03/28/1805/07/21

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHDNCCIH

03/28/1805/07/21

Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH

03/28/1801/07/21

Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH

03/28/1801/07/21

Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIDDKNCINICHDODS

03/27/1805/07/21

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/09/1810/30/18

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/09/1810/30/18

SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNCINEINIAAANIDCRNIDANINR

03/06/1804/05/21

Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required)

Agency: NIH

Institutions: OppNetNCINIANIDCDNCCIHOBSSR

03/02/1804/13/19

Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/27/1810/11/19

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/23/1805/07/21

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/23/1805/07/21

U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/21/1806/15/20

U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/21/1806/15/20

Smart and Connected Health

Agency: NSF

02/21/1812/11/18

Ruth L. Kirschstein National Research Service Award (NRSA)Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNIMHDNLMNCCIHORIP

02/20/1801/07/21

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)

Agency: NIH

Institutions: NCINIANIAAANIAMSNIDCRNIDANIEHSNIGMSNINR

02/20/1801/07/21

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNIMHDNCCIHORIP

02/16/1801/07/21

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIDDKNIEHSNIMHNINDSNINRNIMHDNCCIH

02/16/1801/07/21

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDANIDDKNIEHSNIGMSNIMHNINRNIMHDNCCIH

02/16/1801/07/21

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNLMNIMHNINDSNINRNIMHDNCCIHORIP

02/15/1801/07/21

Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNIAID

02/14/1812/06/18

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/13/1811/19/20

Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

02/13/1811/19/20

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNINDSNIMHDNLMNCCIHNCATSORIP

02/09/1801/07/21

Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANCI

02/08/1809/07/19

Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANCI

02/08/1809/07/19

Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIB

02/07/1809/26/19

Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIB

02/07/1809/26/19

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/07/1806/13/19

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/07/1806/13/19

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1805/07/21

Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/01/1807/05/19

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/30/1804/11/19

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/30/1804/11/19

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/26/1801/25/21

Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/25/1801/25/21

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/25/1801/25/21

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )

Agency: NIH

Institutions: ORWHNCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIP

01/25/1809/07/21

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP

01/16/1804/05/19

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDCRNIDANIGMSNIMHNINRNIMHDNCCIH

01/16/1804/05/19

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDCRNIDANIGMSNIMHNINRNIMHDNCCIH

01/16/1804/05/19

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP

01/16/1804/05/19

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

01/05/1801/07/21

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required)

Agency: NIH

Institutions: NCI

01/05/1801/07/21

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDCRNIBIB

12/21/1701/07/21

International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed

Agency: NIH

Institutions: FICNCI

12/21/1703/06/20

International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required

Agency: NIH

Institutions: FICNCI

12/21/1703/06/20

Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANCINEINICHDNIDCDNIDANINDSNCCIHOBSSR

12/21/1701/07/19

Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional)

Agency: NIH

Institutions: NIBIBNCINCCIH

12/15/1709/07/20

Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANINRNIMHDNCI

12/15/1705/07/20

Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANCCIHNINRNIMHDNCINHLBI

12/15/1705/07/20

Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNIMHDNINDSNINRNLMNCCIHORIPICs

12/13/1701/07/21

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/11/1705/07/21

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/11/1705/07/21

The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/06/1703/12/21

The NCI Transition Career Development Award (K22 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCI

12/06/1703/12/21

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPICs

12/06/1701/07/21

Cancer Research Education Grants Program - Curriculum or Methods Development (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Cancer Research Education Grants Program - Research Experiences (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Cancer Research Education Grants Program - Courses for Skills Development (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINIAAA

11/30/1711/13/20

Image-guided Drug Delivery (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIB

11/30/1711/22/18

Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/30/1706/13/19

Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/30/1706/13/19

Exploratory/Developmental Surgical Disparities Research (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNCINIAMSORWH

11/30/1706/07/19

Surgical Disparities Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNCINIAMSORWHNINRNICHD

11/30/1706/07/19

Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIANCINCCIHNIDCRNIDANIMHNIMHDNINDSNINR

11/29/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIANCINIAAANIDCRNIDDKNIDANIMHNIMHDNINDSNINR

11/29/1709/07/20

NIH Pathway to Independence Award (Parent K99/R00 - Clinical Trial Required)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNINRNIMHDNCCIHNIEHS

11/29/1701/07/21

NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINRNIMHDNLMNCCIHNINDSORIP

11/29/1701/07/21

Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/29/1701/09/20

Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDA

11/28/1701/07/20

Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDA

11/28/1701/07/20

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/28/1704/11/19

Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/28/1704/11/19

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/28/1704/11/19

Population Health Interventions: Integrating Individual and Group Level Evidence (R01) - Clinical Trial Optional

Agency: NIH

Institutions: NCINIDCDNIDAOBSSR

11/22/1705/07/19

Population Health Interventions: Integrating Individual and Group Level Evidence (R21) - Clinical Trials Optional

Agency: NIH

Institutions: OBSSRNCINIDCDNIDA

11/22/1705/07/19

Education and Health: New Frontiers (R03) - Clinical Trial Optional

Agency: NIH

Institutions: OBSSRNCINIANICHDNIDA

11/22/1701/07/19

Education and Health: New Frontiers (R01)- Clinical Trial Optional

Agency: NIH

Institutions: OBSSRNCINIANICHDNIDA

11/22/1701/07/19

Education and Health: New Frontiers (R21)- Clinical Trial Optional

Agency: NIH

Institutions: OBSSRNCINIANICHDNIDA

11/22/1701/07/19

Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNINR

11/21/1703/29/19

Population Health Interventions: Integrating Individual and Group Level Evidence (R21)- Clinical Trials Not Allowed

Agency: NIH

Institutions: OBSSRNCINIDCRNIDCD

11/21/1705/07/19

Population Health Interventions: Integrating Individual and Group Level Evidence (R01) Clinical Trials Not Allowed

Agency: NIH

Institutions: NCINIDCRNIDCDOBSSR

11/21/1705/07/19

NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/21/1701/07/20

Methodology and Measurement in the Behavioral and Social Sciences (R21) Clinical Trials Optional

Agency: NIH

Institutions: OBSSRNCINEINIANIAAANIDCDNCCIHODPORWHOBSSR

11/21/1709/07/19

Methodology and Measurement in the Behavioral and Social Sciences (R01) Clinical Trials Optional

Agency: NIH

Institutions: OBSSRNCINEINIANIAAANIDCDNCCIHODPORWH

11/21/1709/07/19

Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Clinical Trial Required)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNIMHDNCCIHNIEHS

11/21/1701/07/21

Mentored Clinical Scientist Research Career Development Award (Parent K08 - No Independent Clinical Trials)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNIMHDNCCIHNINDS

11/21/1701/07/21

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Agency: NIH

Institutions: NCINEINHGRINIANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHNHLBIORIPNINDSNIAAA

11/21/1701/07/21

NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials)

Agency: NIH

Institutions: NCI

11/20/1701/07/21

NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/20/1701/07/21

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

Agency: NIH

Institutions: NCI

11/17/1701/07/21

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

Agency: NIH

Institutions: NCI

11/17/1701/07/21

Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANIAAANCI

11/17/1709/07/19

Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINIAAA

11/17/1709/07/19

Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINIAAA

11/17/1709/07/19

NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/17/1703/22/19

Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/15/1705/07/19

Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNIEHSODP

11/15/1705/07/20

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINICHDNIDANIAMS

11/13/1701/07/19

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/08/1707/05/19

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/08/1707/16/19

Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNIANIAMSNIDDKNIDANIDCRNINDSNCCIHNIMHD

11/07/1705/07/19

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIBIBNCINEINHGRINIAIDNIAMSNICHDNIDANIEHSNINDS

11/07/1705/07/19

Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCININRNIANIAMSNIDANIDCRNINDSNCCIHNIMHD

11/07/1705/07/19

Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 - No Independent Clinical Trials)

Agency: NIH

Institutions: OppNetNCINIDCRNIDCDNIANIDANIMHDNCCIHOBSSR

11/07/1703/06/19

Bioengineering Research Partnerships (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NIBIBNCINEINIAAANICHDNIDANIEHSNINDS

11/07/1701/07/19

Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

11/07/1701/07/20

Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

11/07/1701/07/20

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/06/1702/14/20

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINICHDORWH

11/06/1701/07/19

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINICHDORWH

11/06/1701/07/19

Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHD

11/06/1705/07/19

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAIDNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSR

11/03/1705/07/19

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHGRINIANIAAANIAIDNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNCCIHODPOBSSRNIMHD

11/03/1705/07/19

Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIA

11/03/1701/07/20

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/03/1701/07/20

Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIA

11/03/1701/07/20

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/03/1701/07/20

NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)

Agency: NIH

Institutions: NCCIH

11/02/1702/29/20

Examination of Survivorship Care Planning Efficacy and Impact (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/02/1701/07/19

Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) Clinical Trial Optional

Agency: NIH

Institutions: OBSSRNCINIBIBNIDCD

11/02/1701/07/19

Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/02/1701/07/19

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHLBI

11/02/1701/07/19

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHLBI

11/02/1701/07/19

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINIAAA

11/01/1705/07/19

Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDDKNCINCCIHODS

11/01/1709/07/19

Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIANCI

11/01/1705/07/20

Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNCINIAAANIDANIEHS

11/01/1701/07/20

Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNCINIAAANIDANIEHS

11/01/1701/07/20

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDCRNIDDK

11/01/1711/05/19

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials)

Agency: NIH

Institutions: NCI

10/31/1701/07/21

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required)

Agency: NIH

Institutions: NCI

10/31/1701/07/21

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/30/1701/07/20

Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCINHLBINIANIDCDNIDANIMHNLMODPOBSSRNIAAA

10/20/1706/07/19

Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANICHDNIDANIMHDNCCIH

10/17/1701/07/21

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)

Agency: NIH

Institutions: NCINIDCR

10/12/1701/07/21

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed

Agency: NIH

Institutions: NCI

10/12/1710/08/20

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

10/12/1710/08/20

Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANIDANCCIH

10/10/1701/07/21

Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

10/03/1701/07/21

Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/29/1701/07/21

Research to Improve Native American Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNIDCR

09/29/1705/14/20

Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNINRNIDCR

09/29/1705/14/20

Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18)

Agency: NIH

Institutions: OppNetNCINIDCRNIDCDNIDANIMHDNCCIHOBSSRNIA

09/19/1703/06/19

Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01)

Agency: NIH

Institutions: NIMHDNCINIAAANIDANIEHS

09/13/1712/04/19

Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R21)

Agency: NIH

Institutions: NIMHDNCINIAAANIDANIEHS

09/13/1712/04/19

Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01)

Agency: NIH

Institutions: NIMHDNCINHLBINIANINR

08/25/1711/15/19

Stimulating Access to Research in Residency (StARR) (R38)

Agency: NIH

Institutions: NHLBINCINIAIDNIA

08/23/1705/12/20

Biology of Lung, and Head and Neck Preneoplasias (R21)

Agency: NIH

Institutions: NCI

08/16/1701/07/21

Biology of Lung, and Head and Neck Preneoplasias (R01)

Agency: NIH

Institutions: NCI

08/15/1701/07/21

The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)

Agency: NIH

Institutions: NCI

08/04/1709/07/20

The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)

Agency: NIH

Institutions: NCI

08/04/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)

Agency: NIH

Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSFIC

08/01/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)

Agency: NIH

Institutions: NHGRINCINIANICHDNIEHSNINDSNIMHD

08/01/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)

Agency: NIH

Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSNINDSNIMHD

08/01/1709/07/20

Assay development and screening for discovery of chemical probes or therapeutic agents (R01)

Agency: NIH

Institutions: NCINIAIDNIDCDNIDANIMH

07/27/1709/07/20

Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)

Agency: NIH

Institutions: NCI

07/20/1709/07/20

Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)

Agency: NIH

Institutions: NCI

07/20/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R21)

Agency: NIH

Institutions: NIANCINIAAANIAMSNIDCRNIDANIMHNIMHDNINDSNINR

06/23/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R01)

Agency: NIH

Institutions: NIANCINCCIHNIAMSNIDCRNIDANIMHNIMHDNINDSNINR

06/23/1709/07/20

Integration of Individual Residential Histories into Cancer Research (R21)

Agency: NIH

Institutions: NCI

06/22/1709/07/20

Integration of Individual Residential Histories into Cancer Research (R01)

Agency: NIH

Institutions: NCI

06/22/1709/07/20

Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01)

Agency: NIH

Institutions: NCI

05/16/1709/07/20

Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21)

Agency: NIH

Institutions: NCI

05/16/1709/07/20

In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)

Agency: NIH

Institutions: NIAIDNCINIAAA

05/12/1705/07/20

HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01)

Agency: NIH

Institutions: NIAIDNCINIAAA

05/12/1705/07/20

In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)

Agency: NIH

Institutions: NIAIDNCINIAAA

05/12/1705/07/20

HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)

Agency: NIH

Institutions: NIAIDNCINIAAA

05/12/1705/07/20

Genomic Community Resources (U24)

Agency: NIH

Institutions: NHGRINCI

05/08/1701/25/20

Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)

Agency: NIH

Institutions: NCI

04/04/1705/07/20

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)

Agency: NIH

Institutions: NCI

04/03/1705/07/20

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)

Agency: NIH

Institutions: NCINHGRINIDCR

03/30/1705/07/20

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)

Agency: NIH

Institutions: NCINHGRINIDCR

03/30/1705/07/20

Innovative Research in Cancer Nanotechnology (IRCN) (R01)

Agency: NIH

Institutions: NCI

03/30/1705/21/20

Centers for AIDS Research (P30)

Agency: NIH

Institutions: NCINHLBINIANIAIDNICHDNIDCRNIDDKNIDANIGMSNIMHNIMHDFIC

03/30/1708/17/19

Developmental Centers for AIDS Research (P30)

Agency: NIH

Institutions: NCINHLBINIANIAIDNICHDNIDCRNIDDKNIDANIGMSNIMHNIMHDFIC

03/30/1708/17/19

Mechanisms and Consequences of Sleep Disparities in the U.S. (R21)

Agency: NIH

Institutions: NIMHDNCINIANIAAANCCIHORWHNIDA

03/29/1707/11/19

Mechanisms and Consequences of Sleep Disparities in the U.S. (R01)

Agency: NIH

Institutions: NIMHDNCINHLBINIANIAAANINRNCCIHORWHNIDA

03/29/1707/11/19

Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01)

Agency: NIH

Institutions: NCI

03/29/1705/07/20

Mechanisms of Alcohol-associated Cancers (R21)

Agency: NIH

Institutions: NIAAANCI

03/13/1709/07/20

Mechanisms of Alcohol-associated Cancers (R01)

Agency: NIH

Institutions: NIAAANCI

03/13/1709/07/20

Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01)

Agency: NIH

Institutions: NCI

03/08/1702/07/19

Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01)

Agency: NIH

Institutions: NCI

03/08/1702/07/19

Inter-organelle Communication in Cancer (R21)

Agency: NIH

Institutions: NCI

03/07/1701/15/20

Inter-organelle Communication in Cancer (R01)

Agency: NIH

Institutions: NCI

03/07/1701/15/20

Energy for Sustainability

Agency: NSF

02/22/1710/22/18

Thermal Transport Processes

Agency: NSF

02/22/1708/15/19

Biophotonics

Agency: NSF

02/22/1708/15/19

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01)

Agency: NIH

Institutions: NCI

02/21/1701/07/19

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21)

Agency: NIH

Institutions: NIMHDNCINIAAA

02/02/1704/04/19

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01)

Agency: NIH

Institutions: NIMHDNCINIAAA

02/02/1704/04/19

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42)

Agency: NIH

Institutions: NIMHNCINHGRINIAMSNIDCRNIDDKNIEHSNCCIHNCATS

02/01/1701/05/20

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)

Agency: NIH

Institutions: NIMHNCINEINHGRINIAMSNIDCRNIDANIDDKNIEHSNIGMSNCCIHNCATS

02/01/1701/05/20

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)

Agency: NIH

Institutions: NCI

12/21/1601/07/20

Fertility Status as a Marker for Overall Health (R01)

Agency: NIH

Institutions: NICHDNIEHSODP

12/19/1605/07/20

Tobacco Use and HIV in Low and Middle Income Countries (R01)

Agency: NIH

Institutions: NCINIDA

12/15/1601/07/20

Tobacco Use and HIV in Low and Middle Income Countries (R21)

Agency: NIH

Institutions: NCINIDA

12/15/1601/07/20

National Cancer Institute Youth Enjoy Science Research Education Program (R25)

Agency: NIH

Institutions: NCI

11/25/1609/07/19

Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01)

Agency: NIH

Institutions: NIMHDNCINIAAANIDCRNIDANIEHS

11/01/1601/07/20

Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R21)

Agency: NIH

Institutions: NIMHDNCINIAAANIDCRNIDANIEHS

11/01/1601/07/20

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01)

Agency: NIH

Institutions: NCI

10/04/1610/28/19

Emerging Global Leader Award (K43)

Agency: NIH

Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH

10/04/1612/14/18

Kidney Precision Medicine Project - Technology Development and Validation (R43/R44)

Agency: NIH

Institutions: NIDDK

09/28/1601/05/20

Kidney Precision Medicine Project - Technology Development and Validation (R41/R42)

Agency: NIH

Institutions: NIDDK

09/28/1601/05/20

Support of Competitive Research (SCORE) Pilot Project Award (SC2)

Agency: NIH

Institutions: NIGMSNCINHLBINIANIAIDNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINDS

09/21/1609/07/19

Support of Competitive Research (SCORE) Research Advancement Award (SC1)

Agency: NIH

Institutions: NIGMSNCINHLBINIANIAIDNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNIEHS

09/21/1609/07/19

"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)

Agency: NIH

Institutions: NCINIDCR

09/07/1609/07/19

"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01)

Agency: NIH

Institutions: NCINIDCR

09/07/1609/07/19

Secondary Analyses of Alcohol and Chronic Disease (R03)

Agency: NIH

Institutions: NIAAANCI

08/10/1609/07/19

Secondary Analyses of Alcohol and Chronic Disease (R01)

Agency: NIH

Institutions: NIAAANCI

08/10/1609/07/19

Social Epigenomics Research Focused on Minority Health and Health Disparities (R21)

Agency: NIH

Institutions: NIMHDNCINIA

07/07/1611/15/18

Social Epigenomics Research Focused on Minority Health and Health Disparities (R01)

Agency: NIH

Institutions: NIMHDNCINIA

07/07/1611/15/18

New Informatics Tools and Methods to Enhance US Cancer Surveillance and Research (UG3/UH3)

Agency: NIH

Institutions: NCI

06/29/1604/16/19

Biological Comparisons in Patient-Derived Models of Cancer (U01)

Agency: NIH

Institutions: NCI

06/24/1603/06/19

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03)

Agency: NIH

Institutions: NCI

06/16/1607/16/19

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21)

Agency: NIH

Institutions: NCI

06/08/1604/11/19

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01)

Agency: NIH

Institutions: NCI

06/08/1604/11/19

Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01)

Agency: NIH

Institutions: NIDCRNIAORWH

05/27/1609/07/19

Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21)

Agency: NIH

Institutions: NIDCRNIAORWH

05/27/1609/07/19

Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01)

Agency: NIH

Institutions: NCI

05/23/1606/13/19

Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21)

Agency: NIH

Institutions: NCI

05/23/1606/13/19

Serious Adverse Drug Reaction Research (R21)

Agency: NIH

Institutions: NHGRINCINIAIDNIAMSNINDS

05/19/1609/07/19

Serious Adverse Drug Reaction Research (R01)

Agency: NIH

Institutions: NHGRINCINIAIDNIAMSNINDSNIMHD

05/19/1609/07/19

Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21)

Agency: NIH

Institutions: NCI

05/16/1609/07/19

Cancer-related Behavioral Research through Integrating Existing Data (R21)

Agency: NIH

Institutions: NCI

05/11/1606/14/19

Cancer-related Behavioral Research through Integrating Existing Data (R01)

Agency: NIH

Institutions: NCI

05/11/1606/07/19

Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21)

Agency: NIH

Institutions: NCI

05/11/1604/11/19

Gene Fusions in Pediatric Sarcomas (R21)

Agency: NIH

Institutions: NCI

05/10/1605/07/19

Dissemination and Implementation Research in Health (R03)

Agency: NIH

Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSR

05/10/1605/07/19

Gene Fusions in Pediatric Sarcomas (R01)

Agency: NIH

Institutions: NCI

05/10/1605/07/19

Neural Regulation of Cancer (R21)

Agency: NIH

Institutions: NCININDS

05/09/1606/27/19

Neural Regulation of Cancer (R01)

Agency: NIH

Institutions: NCININDS

05/09/1606/27/19

Metabolic Reprogramming to Improve Immunotherapy (R21)

Agency: NIH

Institutions: NCI

05/06/1609/07/19

Metabolic Reprogramming to Improve Immunotherapy (R01)

Agency: NIH

Institutions: NCI

05/06/1609/07/19

The Role of Mobile Genetic Elements in Cancer (R21)

Agency: NIH

Institutions: NCINIA

05/05/1609/07/19

The Role of Mobile Genetic Elements in Cancer (R01)

Agency: NIH

Institutions: NCINIA

05/05/1609/07/19

Tools for Cell Line Identification (R43/R44)

Agency: NIH

Institutions: NIGMSNCINIANIAIDNIBIBNIDCRNIDANINDSNCATSORIPORWHNHGRI

04/15/1604/05/19

Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21)

Agency: NIH

Institutions: NCI

04/08/1607/16/19

Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)

Agency: NIH

Institutions: NCI

04/08/1605/07/19

Obesity Policy Evaluation Research (R01)

Agency: NIH

Institutions: NIDDKNCINIANICHDODPOBSSR

04/04/1605/07/19

Emerging Questions in Cancer Systems Biology (U01)

Agency: NIH

Institutions: NCI

03/11/1611/23/18

Imaging and Biomarkers for Early Cancer Detection (U01)

Agency: NIH

Institutions: NCI

01/25/1612/11/18

Education and Health: New Frontiers (R01)

Agency: NIH

Institutions: NCINIANICHDNIDAOBSSR

01/12/1601/07/19

Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01)

Agency: NIH

Institutions: NCI

12/07/1511/17/18

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)

Agency: NIH

Institutions: NCI

08/18/1511/20/18

Advanced Development of Informatics Technologies for Cancer Research and Management (U24)

Agency: NIH

Institutions: NCI

08/18/1511/20/18

Sustained Support for Informatics Resources for Cancer Research and Management (U24)

Agency: NIH

Institutions: NCI

08/18/1511/20/18

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)

Agency: NIH

Institutions: NCI

08/18/1511/20/18

Chemical Measurement and Imaging

Agency: NSF

07/14/0910/31/18
  TOP